Kathy Turner V - 18 Feb 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Senior Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner
Issuer symbol
IDXX
Transactions as of
18 Feb 2022
Net transactions value
+$199,980
Form type
4
Filing time
22 Feb 2022, 16:01:26 UTC
Previous filing
16 Feb 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $100,011 +1,474 +31% $67.85* 6,180 18 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $99,970 +706 +11% $141.60 6,886 18 Feb 2022 Direct
holding IDXX Common Stock 100 18 Feb 2022 by spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -1,474 -100% 0 18 Feb 2022 Common Stock 1,474 $67.85 Direct F2, F4
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -706 -100% 0 18 Feb 2022 Common Stock 706 $141.60 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on February 14, 2021.
F3 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on February 14, 2022.
F4 Not applicable.